Ligand ID: RO7


Drugbank ID:
DB08915
(Aleglitazar)



Indication:
Investigated for use in patients with type II diabetes to reduce their risks of cardiovascular mortality and morbidity.


Get human targets for RO7 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'RO7' AND SARS-RELATED PROTEINS ONLY

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
View Interface RMSD Seq.
Identity (%)
HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
1q2w 3C-LIKE PROTEASE
(SARSr-CoV)
5 / 12
GLY B 124
SER B 144
HIS B 163
TYR B 161
VAL B  13
1.49A22.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
1uk3 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.35A22.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
VAL B1114
CYH B1128
ILE B1106
ILE B1200
VAL B1204
1.78A22.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)
4 / 7
LEU D  19
GLN E  93
LEU A  60
VAL A  16
1.08A18.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2amd 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
SER A 147
HIS A 163
LEU A  27
VAL A  20
HIS A 164
1.41A22.29
None
9IN  A1001 (-3.8A)
9IN  A1001 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 7
LEU E1168
GLN C 915
LEU D1179
LEU B 920
LYS A 914
1.71A12.35
None
None
ACE  B 913 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2dd8 IGG HEAVY CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARSr-CoV)
5 / 12
VAL S 496
TYR S 436
ILE S 405
ILE H  56
TYR S 484
1.65A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2ga6 ORF1A POLYPROTEIN
(SARSr-CoV)
5 / 12
CYH T  74
CYH T  73
SER T  72
ILE T  55
ILE T  99
1.74A20.38
ZN  T 998 (-2.2A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2gt8 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY A 120
CYH A 117
SER A 144
TYR A 126
VAL A  13
1.29A22.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.52A22.51
None
WR1  A 601 (-3.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)
5 / 12
VAL D 291
SER B 241
MET D 271
ILE D 269
ILE B 235
1.52A23.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)
4 / 7
LEU A 248
VAL A 320
LEU A 297
LEU A  75
0.97A23.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)
5 / 7
LEU A  86
GLN A  19
VAL A 148
LEU A  32
LYS A  97
1.72A22.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.47A22.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2qc2 3C-LIKE PROTEINASE
(-)
5 / 12
GLY B 124
SER B 144
HIS B 163
TYR B 161
VAL B  13
1.40A22.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 7
LEU A  86
GLN A  19
VAL A 148
LEU A  32
LYS A  97
1.61A22.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2qiq REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.51A22.65
None
CYV  A 302 ( 4.2A)
CYV  A 302 (-3.9A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2vj1 MAIN PROTEINASE
(SARSr-CoV)
5 / 12
VAL B  20
CYH B 145
SER B 144
HIS B 172
TYR B 126
1.69A23.71
None
XP1  B1304 (-1.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2vj1 MAIN PROTEINASE
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.46A22.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)
4 / 7
LEU A 161
VAL A  67
LEU A  59
LEU A 180
1.10A20.79
None
None
NA  A1295 (-4.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
2xyr PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)
4 / 7
LEU A 161
VAL A  67
LEU A  59
LEU A 180
1.06A20.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3atw 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.44A22.57
None
HSV  C   5 (-3.6A)
HSV  C   5 (-4.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)
4 / 7
LEU B 236
GLN B 526
VAL B 581
LEU B 450
1.02A18.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)
5 / 12
SER B 170
TYR B 497
ILE B 151
HIS B 493
VAL B 491
1.72A18.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3e91 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY B 124
SER B 144
HIS B 163
TYR B 161
VAL B  13
1.47A22.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3eaj 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.52A22.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3m3s 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY B 124
SER B 144
HIS B 163
TYR B 161
VAL B  13
1.51A22.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3m3t 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 7
LEU A  86
GLN A  19
VAL A 148
LEU A  32
LYS A  97
1.63A22.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY A 124
SER A 144
HIS A 163
TYR A 161
VAL A  13
1.45A22.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)
4 / 7
LEU A 161
VAL A  67
LEU A  59
LEU A 180
1.08A20.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3scj ACE2
(Homo
sapiens)
4 / 7
LEU B 236
GLN B 526
VAL B 581
LEU B 450
1.04A18.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)
5 / 12
SER A 170
TYR A 497
ILE A 151
HIS A 493
VAL A 491
1.64A18.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)
4 / 7
LEU B 236
GLN B 526
VAL B 581
LEU B 450
1.01A18.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY B 124
SER B 144
HIS B 163
TYR B 161
VAL B  13
1.46A22.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
VAL A 114
CYH A 128
ILE A 106
ILE A 200
VAL A 204
1.79A24.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLY B 124
SER B 144
HIS B 163
TYR B 161
VAL B  13
1.50A21.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
5f22 NSP8
NSP7
(SARSr-CoV)
5 / 7
LEU B 133
GLN A  36
LEU A  18
VAL A  58
LEU A  65
1.67A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
5tl7 REPLICASE
POLYPROTEIN 1AB
UBIQUITIN-LIKE
PROTEIN ISG15
(Mus
musculus;
SARSr-CoV)
5 / 12
VAL C 115
TYR D 265
MET D 209
VAL D 166
TYR D 274
1.76A17.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
5x5f S PROTEIN
(MERS-CoV)
5 / 12
GLY B 572
LEU B 415
VAL B 420
LEU B 441
TYR B 438
1.32A11.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)
4 / 7
LEU C 959
GLN C 984
LEU C 745
LEU C 735
1.01A12.68
LEU  C 959 ( 0.6A)
GLN  C 984 ( 0.6A)
LEU  C 745 ( 0.5A)
LEU  C 735 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)
4 / 7
LEU B 959
GLN B 984
LEU B 745
LEU B 735
1.08A12.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
CYH A  19
CYH A 133
ILE A 152
MET A 151
VAL A 102
1.56A12.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
4 / 7
LEU C 615
GLN C 630
VAL C 596
LEU A 831
1.12A12.92
None
NAG  C1311 (-3.1A)
None
NAG  C1311 (-4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6cs2 ACE2
(Homo
sapiens)
5 / 12
SER D 170
TYR D 497
ILE D 151
HIS D 493
VAL D 491
1.79A18.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6m17 ACE2
(Homo
sapiens)
5 / 12
SER D 170
TYR D 497
ILE D 151
HIS D 493
VAL D 491
1.56A16.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6m17 ACE2
(Homo
sapiens)
4 / 7
LEU B 236
GLN B 526
VAL B 581
LEU B 450
1.11A16.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)
4 / 7
LEU A 424
LEU A 244
LYS A 409
LEU A 389
1.09A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)
5 / 12
VAL C 505
SER C 291
TYR C 292
ILE C  15
VAL C 441
1.64A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6vw1 ACE2
(Homo
sapiens)
4 / 7
LEU A 236
GLN A 526
VAL A 581
LEU A 450
1.01A18.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
5 / 12
GLY L  64
TYR L  36
ILE L  75
LEU L  33
TYR L  91
1.65A19.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
GLN L  38
LEU L  46
VAL L  58
LEU L  73
1.73A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
GLN L 147
LEU L 181
VAL L 133
LEU L 154
1.46A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)
4 / 7
LEU H  82
GLN H   6
VAL H  67
LEU H   4
1.71A19.49
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
GLN L  38
LEU L  73
VAL L  58
LEU H  45
1.68A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
GLN L  38
LEU L  73
LEU L  11
LEU H  45
1.71A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
GLN L 147
LEU L 175
VAL L 115
LEU L 201
1.51A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
LEU L  78
GLN L  38
LEU L  11
LEU H  45
1.49A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
LEU L 175
GLN L 147
LEU L 181
VAL L 133
1.57A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
GLN L  38
LEU L  47
LEU L  78
LEU H  45
1.79A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 7
LEU L  73
GLN L  42
VAL L 104
LEU L  78
1.59A18.77
None
SO4  L 302 (-4.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
6yla LIGHT CHAIN
(Homo
sapiens)
5 / 12
GLY C  70
TYR C  42
ILE C  81
LEU C  39
TYR C  97
1.74A20.28
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
6yla LIGHT CHAIN
(Homo
sapiens)
5 / 12
GLY L  70
TYR L  42
ILE L  81
LEU L  39
TYR L  97
1.73A20.28
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6yla LIGHT CHAIN
(Homo
sapiens)
4 / 7
GLN C 153
LEU C 181
VAL C 121
LEU C 207
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G8I_A_RO7A1_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR ALPHA)
6ym0 LIGHT CHAIN
(Homo
sapiens)
4 / 7
GLN L 153
LEU L 187
VAL L 139
LEU L 160
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
6ym0 LIGHT CHAIN
(Homo
sapiens)
5 / 12
GLY L  70
TYR L  42
ILE L  81
LEU L  39
TYR L  97
1.75A20.28
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
6yor IGG L CHAIN
(Homo
sapiens)
5 / 12
GLY L  70
TYR L  42
ILE L  81
LEU L  39
TYR L  97
1.72A20.28
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G9E_A_RO7A1_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
6yor IGG L CHAIN
(Homo
sapiens)
5 / 12
GLY C  70
TYR C  42
ILE C  81
LEU C  39
TYR C  97
1.73A20.28
None